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Abstract
Background: The use of great apes (GA) in invasive biomedical research is one of the most debated topics in animal
ethics. GA are, thus far, the only animal group that has frequently been banned from invasive research; yet some
believe that these bans could inaugurate a broader trend towards greater restrictions on the use of primates and
other animals in research. Despite ongoing academic and policy debate on this issue, there is no comprehensive
overview of the reasons advanced for or against restricting invasive research with GA. To address this gap, we conducted a systematic review of the reasons reported in the academic literature on this topic.
Methods: Seven databases were searched for articles published in English. Two authors screened the titles, abstracts,
and full texts of all articles. Two journals specialized in animal ethics, and the reference lists of included articles were
subsequently also reviewed.
Results: We included 60 articles, most of which were published between 2006 and 2016. Twenty-five articles argued
for a total ban of GA research, 21 articles defended partial restrictions, and 14 articles argued against restrictions.
Overall, we identified 110 reason types, 74 for, and 36 against, restricting GA research. Reasons were grouped into
nine domains: moral standing, science, welfare, public and expert attitudes, retirement and conservation, respect and
rights, financial costs, law and legal status, and longer-term consequences.
Conclusion: Our review generated five main findings. First, there is a trend in the academic debate in favor of
restricting GA research that parallels worldwide policy changes in the same direction. Second, in several domains (e.g.,
moral standing, and respect and rights), the reasons were rather one-sided in favor of restrictions. Third, some prominent domains (e.g., science and welfare) featured considerable engagement between opposing positions. Fourth,
there is low diversity and independence among authors, including frequent potential conflicts of interests in articles
defending a strong position (i.e., favoring a total ban or arguing against restrictions). Fifth, scholarly discussion was
not the norm, as reflected in a high proportion of non-peer-reviewed articles and authors affiliated to non-academic
institutions.
Keywords: Biomedical research, Great apes, Ethics, Systematic review, Animal experimentation
Background
Historically, the debate over the use of animals in biomedical research has been divided between those who
argue that animal research is necessary for medical
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progress and therefore justified, and those who favor
restricting or even banning animal research. But even
among proponents of animal research, there is growing
concern regarding animal welfare. Indeed, many countries have introduced regulations aimed at improving
the conditions under which animals are used in research.
Perhaps the most notable development in the field of animal research regulation concerns the use of great apes

© The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which
permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the
original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or
other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line
to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this
licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativeco
mmons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Aguilera et al. BMC Med Ethics

(2021) 22:15

(chimpanzees, bonobos, gorillas, and orangutans).1 In
2015, the (U.S.) National Institutes of Health joined the
governments of Australia, New Zealand, Japan, and the
European Union (E.U.) in banning or severely limiting
experiments on chimpanzees [1].
Some commentators have suggested that the turn to
ban invasive biomedical research with great apes (hereafter, GA) could represent the beginning of a more general
trend towards increasing restrictions on the use of primates and other animals in research [2–4].2 Recent developments seem to confirm this hypothesis. For example,
in 2018, a U.S. Senator introduced legislation that would
severely restrict the use of non-human primates in biomedical research, and in 2020 the U.S. National Academies of Sciences, Engineering, and Medicine published
a report that recommended more stringent conditions
on the use of dogs in research funded by the U.S. Department of Veterans Affairs (NASEM) [5, 6].
Since GA constitute the only animal group that has
consistently been banned from invasive research in
many countries, the reasons given for and against such
a ban—or other restrictions—can provide a basis for
judging whether invasive research on other animal species should be restricted. However, these reasons are
scattered in the literature and often come from sources
swayed by one or the other side of the debate. To address
these concerns, we conducted a systematic review of the
reasons advanced for and against restricting research
with GA. Our review is a valuable contribution to the
debate over whether GA should be used in invasive biomedical research in three main respects. First, by mapping the ethical debate on this issue, this review identifies
argumentative patterns, gaps, and underrepresented concerns, thereby revealing alternative directions for advancing the debate. Second, our review can provide a basis
for judging the adequacy of reasons given for and against
extending research restrictions to other animal species or
groups. Finally, it can help policymakers and regulators
make fully informed and minimally biased decisions concerning the regulation of GA research.

1

To be more precise, great apes, or hominids, comprise seven species of
non-human great apes: Pan troglodytes (chimpanzees); Pan paniscus (bonobos); Gorilla gorilla and Gorilla beringei (gorillas); and Pongo abelii, Pongo
pygmaeus, and Pongo tapanuliensis (orangutans). Humans are also considered great apes, but since our review focuses on biomedical research with
non-human animals, we use ‘great apes’ to denote the non-human species
just mentioned.

2

As we explain later, by ‘invasive biomedical research’ we mean research
that is potentially harmful and not primarily aimed to benefit the individual
or the species to which it belongs.

Page 2 of 20

Methods
We performed a systematic review of reasons, a type of
review that provides a comprehensive and systematic
account of the reasons given in the literature in connection with an ethical issue, and that is primarily descriptive rather than evaluative [7]. We followed the PRISMA
Statement and checklist in formulating this review [8].
Search strategy

A medical librarian searched seven bibliographic databases covering the health sciences (PubMed, Global
Health), life sciences (Web of Science: Core Collection,
Web of Science: BIOSIS Citation Index, Web of Science:
Zoological Record) and ethics (EthxWeb, PhilPapers),
using a combination of keywords and controlled vocabularies. We limited the searches to English language and
did not limit by publication date. The searches were completed in July 2019 and updated in July 2020. EndNote X9
(Clarivate Analytics) was used to collect the citations and
identify duplicates. The final search strategies for each
database are listed in Additional file 1: Table 1.
We also hand-searched the electronic table of contents
of two journals specialized in animal ethics (Between the
Species and Journal of Animal Ethics) to identify additional relevant articles. Finally, we screened the reference
lists of included articles for additional articles to consider.
Article selection and inclusion criteria

The first and second authors (BA, JPG) independently
screened the retrieved articles using pre-established
inclusion or exclusion criteria in two steps: first by
reviewing titles and abstracts, and then by reviewing the
full texts of those included in the first step. Google Sheets
was used for the article screening process. The two
authors jointly resolved disagreements over the eligibility
of publications, and any remaining disagreements were
resolved through discussion with the third author (DD).
We included a publication if all of the following criteria
were met:
1. It specifically discussed the ethics or regulation of
research with GA (or some of the GA species).
2. It addressed reasons why the use of GA for research
should or should not be restricted or banned.
3. It considered research that was invasive (that is,
potentially harmful and not primarily aimed to benefit the individual or the species to which it belongs).
4. It was an article (understood broadly, to include various types of journal writings such as commentaries
and letters) published in English in an academic journal.
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Inclusion criteria (1) and (2) excluded purely empirical
veterinary or biomedical research and articles not endorsing reasons for or against restricting GA research (e.g.,
news articles or purely descriptive reviews of the debate).
Articles discussing the regulation of animal research
more generally were eligible only if they offered reasons
that explicitly applied to GA research (e.g., in claiming
that there is a stronger case for restricting GA research
than for research involving other types of animals). Articles focusing on the ethics of GA research were included
only if they addressed research regulation. We employed
criterion (3) to exclude articles that addressed noninvasive forms of GA research only (e.g., purely observational
studies), as well as research intended to benefit GA exclusively. Hereafter, unless otherwise specified, references
to “GA research” should be understood to refer only to
invasive, nontherapeutic GA biomedical research.
Data extraction and analysis

The first and second authors (BA, JPG) independently reviewed the full texts of the included articles
and extracted reasons for or against restriction of GA
research. Google Sheets was used for the data extraction
and coding. We counted a claim as a reason when it was
advanced independently by the author; we did not count
mentions of others’ claims as a reason unless they were
actively endorsed by the author. We assigned mentions of
reasons to specific categories (reason types) and grouped
them into nine broader domains. This was carried out by
highlighting and labeling passages of reasons, and grouping them into categories, using inductive and deductive
content analysis processes [9, 10]. Depending on the
overall position taken by the authors, we categorized
articles favoring restrictions into total ban or partial
restrictions, and those opposing restrictions into against
restrictions. For comprehensiveness, we categorized articles into against restrictions even if they adopted this
position implicitly: by taking a favorable attitude towards
GA research, without specifically mentioning restrictions. In general, with the exception of some articles
supporting partial restrictions that contained a mix of
reasons for either position, reasons within articles were
either strictly for or strictly against GA research.
Within some domains, we classified reason types
according to subdomains. When a reason type seemed to
apply to more than one domain, we classified the reason
under the domain we considered most appropriate based
both on its content and on how informative it would be
to the reader. The first and second authors (BA, JPG)
performed this process in close collaboration, through
frequent meetings to revise the data extraction and
analysis in order to concur on the coding of the reasons.
For remaining disagreements, the third author (DD)
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participated in discussions until consensus was reached
on how to resolve the disagreement in coding.
We classified journals using the All Science Journal
Classification (ASJC) scheme in physical sciences, health
sciences, life sciences, and social sciences & humanities (SS&H) [11]3 When the journal fit into more than
one field, or the journal was not listed in ASJC (which
occurred in three cases), we used the journal’s webpage
description to determine the journal’s classification.
One journal (Bulletin of the National Society for Medical
Research) is no longer active so we based its classification
on its title.
We identified an article as posing a potential conflict of
interest when the journal in which the article was published or any of the articles’ authors were affiliated with
or sponsored by an institution that, according to its webpage (e.g., a mission or vision statement), takes a position
in favor of or against the use of GA or animals more generally in biomedical research (Additional file 1: Table 2).
We developed this method as none of the articles in our
review disclosed conflicts of interest as indicated by a
conflict of interest statement in the article.

Results
Article characteristics

The database searches yielded 801 unique records.
After title and abstract screening, full text screening,
and perusing reference lists, 60 articles were included
for data extraction and analysis (see Fig. 1; all included
publications are listed in Table 1). The dates of publication ranged from 1982 to 2018, but 40 (67%) articles were
published between 2006 and 2016 (see Fig. 2). Nearly half
of the articles (42%) in our final list were types of opinion
pieces (e.g., commentaries, letters, and editorials) (see
Table 2). All articles discussed the research use of chimpanzees, which are the GA species that has historically
been the most frequently used in invasive biomedical
research. Other GA species were also mentioned in 18
articles, but often in passing or to provide some context
for the discussion of chimpanzee research.
Most authors were affiliated with an entity based in the
U.S. (66%) or the U.K. (20%). Most U.K.-based authors
favored a total ban (92%), whereas U.S.-based authors
were almost evenly distributed between advocating for a
total ban (31%), for partial restrictions (38%), or against
restrictions (31%). The remaining authors were based in
3

Roughly, health sciences journals cover research on human health, disease
and health professions; life sciences journals cover biological and animal
research; and social sciences & humanities journals cover different branches
of those disciplines, including bioethics. To simplify the exposition, we sometimes refer to health sciences and life sciences journals together as ‘scientific
journals’. No publication included in our review corresponded to a physical
sciences journal.
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Records identified through database
searching
(n = 1628)

Additional records identified through
other sources
(n = 1)

Total search (n = 1629)
Duplicates (n = 828)

Titles/abstracts screened
(n = 801)

Records excluded (n = 673)
Not academic article=92
Other language=1
Primary empirical research=331

Full-text articles excluded
Full-text articles assessed
for eligibility
(n = 128)

(n = 78)
Not relevant topic=21
No reason mentioned=58

Perusal of reference lists of
included studies (n = 10)

Records included in the
systematic review
(n = 60)

Fig. 1 PRISMA flow chart of the selection process

Italy (2), The Netherlands (2), Australia (1) and New Zealand (1). Institution-wise, 52% of corresponding authors
were affiliated to a private institution or foundation, 19%
to a public university, 13% to a private university, and 8%
to a governmental organization.
In general, most articles were published in scientific
journals (health sciences 45%, life sciences 28%) while
27% were in social sciences & humanities (SS&H) journals. However, some domains departed significantly from
this distribution, as indicated in each relevant domain
below. Finally, potential conflicts of interests were common, especially in articles defending strong positions:

84% in articles defending a total ban, 23% in articles
favoring partial restrictions, and 50% in articles against
restrictions.4
Positions taken by the authors

With respect to the overall positions taken by the authors
of the included articles, 25 (42%) articles argued for a
total ban of GA research, 21 (35%) articles defended

4

Within articles identified as posing a potential conflict of interests, both articles favoring restrictions and articles against restrictions were associated with
institutions taking the same position towards animal research.
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Table 1 Included and analyzed publications in alphabetical order
[12] Altevogt BM, Pankevich DE, Pope AM, Kahn JP. Guiding limited use of chimpanzees in research. Science. 2012;335:41–2
[13] Bailey J. An examination of chimpanzee use in human cancer research. Altern Lab Anim. 2009;37:399–416
[14] Bailey J. Biomedical research involving chimpanzees. Altern Lab Anim. 2011;39:413–4
[15] Bailey J. Lessons from chimpanzee-based research on human disease: the implications of genetic differences. Altern Lab Anim. 2011;39:527–40
[2]

Balls M. Chimpanzee medical experiments: Moral, legal and scientific concerns. Altern Lab Anim. 1995;23:607–14

[16] Balls M. Primates in medical research: The plot thickens. Altern Lab Anim. 2006;34:271–2
[17] Balls M. Time for real action on chimpanzees and other hominids. Altern Lab Anim. 2007;35:191–5
[18] Beauchamp TL, Ferdowsian HR, Gluck JP. Where are we in the justification of research involving chimpanzees? Kennedy Inst Ethics J.
2012;22(3):211–42
[19] Beauchamp TL, Wobber V. Autonomy in chimpanzees. Theor Med Bioeth. 2014;35:117–32
[20] Bennett AJ. New era for chimpanzee research: Broad implications of chimpanzee research decisions. Dev Psychobiol. 2015; https://doi.
org/10.1002/dev.21294
[21] Bennett AJ, Panicker S. Broader impacts: International implications and integrative ethical consideration of policy decisions about US chimpanzee
research. Am J Primatol. 2016; https://doi.org/10.1002/ajp.22582
[22] Bloomsmith MA, Schapiro SJ, Strobert EA. Preparing chimpanzees for laboratory research. ILAR J. 2006; 47(4):316–25
[23] Bradshaw GA, Capaldo T, Lindner L, Grow G. Building an inner sanctuary: Complex PTSD in chimpanzees. J Trauma Dissociation. 2008;9:8–34
[24] Capaldo T, Peppercorn M. A review of autopsy reports on chimpanzees in or from US laboratories. Altern Lab Anim. 2012;40:259–69
[25] Cavalieri P. Ethics, animals and the nonhuman great apes. J Biosci. 2006;31(5):509–12
[3]

Cavalieri P, Singer P. The great ape project: Premises and implications. Altern Lab Anim. 1995;23:626–31

[26] Conlee KM. Chimpanzees in research and testing worldwide: Overview, oversight, and applicable laws. AATEX 14 (Special Issue). 207;14:111–18
[27] Conlee KM, Hoffeld EH, Stephens ML. A demographic analysis of primate research in the United States. Altern Lab Anim. 2004;32 Suppl 1:315–22
[28] de Waal FB. Research chimpanzees may get a break. PLoS Biol. 2012;10(3):1–4
[29] DeGrazia D. Human-animal chimeras: Human dignity, moral status, and species prejudice. Metaphilosophy. 2007;38:309–29; https://doi.org/10.111
1/j.1467-9973.2007.00476.x
[30] DeGrazia D. Nonhuman primates, human need, and ethical constraints. Hastings Cent Rep. 2016;46(4):27–28; https://doi.org/10.1002/hast.601
[31] Eichberg JW, Speck JT. Establishment of a chimpanzee retirement fund: Maintenance after experimentation. J. of Med. Primatol. 1988;17:71–6
[32] Fenton A. Can a chimp say "no"? Reenvisioning chimpanzee dissent in harmful research. Camb Q Healthc Ethics. 2014;23:130–9
[33] Fenton A. On the need to redress an inadequacy in animal welfare science: Toward an internally coherent framework. Biol Philos. 2012;27:73–93;
https://doi.org/10.1007/s10539-011-9291-1
[34] Fultz PN. Nonhuman primate models for AIDS. Clin Infect Dis. 1993;17 Suppl 1:S230–35
[35] Gagneux P, Moore JJ, Varki A. The ethics of research on great apes. Nature. 2005;437:27–9
[36] Goodall J. Ending research on non-human primates. ALTEX. 2005;22:14–8
[37] Goodall J. Why is it unethical to use chimpanzees in the laboratory. Altern Lab Anim. 1995;23:615–20
[38] Great ape debate. Nature. 2011;474:252; https://doi.org/10.1038/474252a
[39] Gruen L. The end of chimpanzee research. Hastings Cent Rep. 2016; https://doi.org/10.1002/hast.604
[40] Jacobs L. The use and the care of the chimpanzee. Bull Natl Soc Med Res. 1982;33(2):1–2
[41] Johnson K. The misuse of chimpanzees in biomedical experiments. Altern Lab Anim. 1995;23:648–51
[42] Johnson J, Barnard ND. Chimpanzees as vulnerable subjects in research. Theor Med Bioeth. 2014;35:133–141; https://doi.org/10.1007/s11017-0149286-4
[43] Jones RC, Greek R. A review of the Institute of Medicine’s analysis of using chimpanzees in biomedical research. Sci Eng Ethics. 2014;20:481–504;
https://doi.org/10.1007/s11948-013-9442-7
[44] Kahn J. Lessons learned: Challenges in applying current constraints on research on chimpanzees to other animals. Theor Med Bioeth. 2014;35:97–
114; https://doi.org/10.1007/s11017-014-9284-6
[45] Kantin H, Wendler D. Is there a role for assent or dissent in animal research? Camb Q Healthc Ethics. 2015;24:459–72; https://doi.org/10.1017/S0963
180115000110
[46] Knight A. Assessing the necessity of chimpanzee experimentation. ALTEX. 2012;29:93–2
[47] Knight A. The beginning of the end for chimpanzee experiments? Philos Ethics Humanit Med. 2008; https://doi.org/10.1186/1747-5341-3-16
[48] Knight A. The poor contribution of chimpanzee experiments to biomedical progress. J Appl Anim Welf Sci. 2007;10(4):281–308
[49] Kraska, K. Are we justified in conducting invasive research on captive apes for their wild counterparts? Soc Anim. 2018;26:598–615
[50] LaManna JC. Animal models: Ads against chimp research criticized. Nature. 2012;483:275
[51] Lanford RE, Walker CM, Lemon SM. The chimpanzee model of viral hepatitis: Advances in understanding the immune response and treatment of
viral hepatitis. ILAR J. 2017;58(2):172–89
[52] Latzman RD, Hopkins WD. Letter to the editor: Avoiding a lost opportunity for psychological medicine: importance of chimpanzee research to the
National Institutes of Health portfolio. Psychol Med. 2016;46:2445–7

Aguilera et al. BMC Med Ethics

(2021) 22:15

Page 6 of 20

Table 1 (continued)
[53] Lopresti-Goodman SM, Bezner J, Ritter C. Psychological distress in chimpanzees rescued from laboratories. J Trauma Dissociation. 2015;16(4):349–
66; https://doi.org/10.1080/15299732.2014.1003673
[54] McKellips P. The slippery slopes with Tommy, Kiko, Hercules, Leo and Duke. Lab Anim (NY). 2014;43(2):69
[55] Participants, Primate Workshop 1987, Washington DC. Recommendations to USDA on improving conditions of psychological well-being for captive chimpanzees. Altern Lab Anim. 1988;15:255–60
[56] Prince AM. Is the conduct of medical research on chimpanzees compatible with their rights as a near-human species? Between Species. 1993
[57] Prince AM, Allan J, Andrus L, Brotman B, Eichber J, Fouts R, et al. Virulent HIV strains, chimpanzees, and trial vaccines. Science. 1999;283(5405):1117
[58] Prince AM, Brotman B, Garnham B, Hannah AC. Enrichment, rehabilitation, and release of chimpanzees used in biomedical research: procedures
used at Vilab II, the New York Blood Center’s Laboratory in Liberia, West Africa. Lab Animal. 1990;19:29–37
[59] Prince AM, Goodall J, Brotman B, Dienske H, Schellekens H, Eichberg JW. Appropriate conditions for maintenance of chimpanzees in studies with
blood-borne viruses: An epidemiologic and psychosocial perspective. J. Med. Primatol. 1989;18:27–42
[60] Reynolds V. Moral issues in relation to chimpanzees in gield studies and experiments. Altern Lab Anim. 1995; https://doi.org/10.1177/0261192995
02300512
[61] Rowan AN. The uncertain future of research chimpanzees. Science. 2007;315:1493
[62] Rowan A, Conlee K, Bettauer R. End invasive chimp research now. Nature. 2011;475:296
[63] Taylor R. A step at a time: New Zealand’s progress toward hominid rights. Animal Law. 2001;7(35):35–43
[64] Thew M, Bailey J, Balls M, Hudson M. The ban on the use of chimpanzees in biomedical research and testing in the UK should be made permanent
and legally binding. Altern Lab Anim. 2012;40:3–8
[65] Van Akker R, Balls M, Eichberg JW, Goodall J, Heeney JL, Osterhaus A, et al. Chimpanzees in AIDS research – a biomedical and bioethical perspective. J. Med. Primatol. 1994;23:49–51
[66] VandeBerg JL. Reclassification of captive chimpanzees as endangered would cost lives. Journal of Medical Primatology. 2013;42:225–8; https://doi.
org/10.1111/jmp.12074
[67] VandeBerg S. A unique biomedical resource at risk. Nature. 2005;437:30–2
[68] Varki A. Fate of ’retired’ research chimps. Nature. 2010;467:1047
[69] Wise SM. The entitlement of chimpanzees to the common law writs of habeas corpus and de homine replegiando. Golden Gate University Law
Review. 2007;37(2):219–80

partial restrictions, and 14 (23%) articles argued against
restrictions. Of those that defended partial restrictions,
13 (22%) argued for restrictions consistent with protections for certain human subjects—in particular, those
who cannot provide informed consent or are designated
as vulnerable (e.g., infants)—while 8 (13%) argued for less
stringent protections. Despite the range of views identified, authors rarely cited other articles defending an
opposing view: while 22 (37%) articles cited other articles
approvingly (i.e., to support a proposed viewpoint) only 2
(3%) articles cited other articles to engage with an opposing viewpoint.
Reasons for and against restricting invasive research
with GA

We identified a total of 110 reasons: 74 in favor of and
36 against restricting GA research. These reasons were
mentioned a total of 315 times of which 238 were in favor
of and 77 against restrictions. We categorized these reasons into the following nine domains, listed in descending order of frequency: (1) Moral Standing, (2) Science,
(3) Welfare, (4) Public and Expert Attitudes, (5) Conservation and Retirement, (6) Respect and Rights, (7) Financial Costs, (8) Law and Legal Status, and (9) Longer-term

Consequences. Table 3 includes a detailed account of the
reasons in each domain and their frequency.
Moral standing

This domain comprises reasons that appeal either directly
or indirectly to the moral standing of GA as grounds for
giving them special protections. Reasons in this domain
were the most frequently mentioned in the literature and
were overwhelmingly in favor of restricting GA research
(103 mentions in favor and 1 against). Authors offered
various grounds for granting GA special protections,
which we further categorized in descending order of frequency into four subdomains: (a) Similarity to Humans,
(b) Cognitive and Consciousness-related Capacities, (c)
Double Standards, and (d) Vulnerability.
Similarity to humans Many authors appealed to perceived similarities between GA and humans as grounds
for giving GA special protections. We interpreted this
reasoning as an argument from analogy, inferring a similar moral standing between humans and GA given that
they share relevant similarities. Reasons in this domain
figured predominantly in health sciences journals. Furthermore, reasons in this domain were largely used in
favor of restricting GA research (59 mentions in favor
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Fig. 2 Number of publications included in this systematic review between 1980 and 2020, in relation to relevant historical events and names of
countries/institutions in which great ape research has been severely restricted or banned

and 1 against). Some of the most frequently cited reasons conceived of the relevant similarities in terms of
Table 2 Characteristics of publications included in this
systematic review
Publication characteristics

N

Percentage

a

Affiliation of corresponding author
Private Institution or Foundation

33

52

Public University

12

19

Private University

8

13

Governmental Organization

5

8

None

5

8

Type of journal
Social Sciences & Humanities

16

27

Health Sciences

27

45

Life Sciences

17

28

Type of publication
Original article

32

53

Commentary

14

23

Letter

8

13

Editorial

3

5

Conference proceedings

2

3

Workshop proceedings

1

2

a

The numbers add up to more than the total number of 60, as some authors
had more than one affiliation

cognitive and consciousness-related capacities. Authors
supported these reasons by invoking several more specific capacities (see Table 4). Other reasons for granting
GA special protections on grounds of their similarity
to humans appealed to genetic, evolutionary, developmental, and behavioral characteristics. It is worth
noting that the only reason against restrictions in this
subdomain was that while GA may seem very similar to
humans with respect to certain behaviors, this seeming
similarity may be the result of training or mimicry.
Cognitive and consciousness‑related capacities Reasons in this subdomain appeal to granting GA special
protections based on their cognitive and consciousness-related capacities, regardless of their similarity to
humans. These reasons were raised most frequently in
SS&H journals and were solely used in favor of restrictions. Drawing on the literature on moral standing, we
interpreted these reasons as giving moral weight to the
possession of certain capacities. Since these were often
put forward as independent claims, we distinguished
between reasons appealing to consciousness-related
capacities and reasons referring to other sophisticated
cognitive capacities attributed to GA. As in the previous
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Table 3 Reasons for and against restricting invasive research with great apes (GA)
Domain

Position Subdomain and reasons

N

References

104

Moral standing
Pro

Con

Pro

Pro

Pro

Similarity to humans

60

GA possess certain cognitive and behavioral
capacities similar to humans, and thus deserve
special protections

15

[2, 3, 17, 18, 25, 27, 28, 30, 32, 36, 37, 39, 55, 59, 60]

GA and humans have a similar evolutionary origin,
so GA deserve special protections

10

[3, 18, 25, 37, 39, 55, 59, 60, 63, 69]

GA possess certain conscious experiences similar
to humans, and thus deserve special protections

9

[2, 17, 18, 28, 32, 37, 39, 55, 59]

Like humans, GA exhibit moral behavior, and thus
deserve special protections

8

[2, 18, 28, 36, 37, 39, 47, 55]

GA are greatly anatomically and/or physiologically
similar to humans, and thus deserve special
protections

6

[2, 18, 27, 32, 37, 55]

There is great genetic similarity between GA and
humans, so GA deserve special protections

5

[2, 35, 37, 55, 69]

Like humans, GA have a long period of childhood
dependency on the mother, so they deserve
special protections

3

[36, 37, 59]

GA are very similar to humans (unspecified), and
thus deserve special protections

2

[3, 65]

GA possess cognitive capacities similar to those of
cognitively disabled humans, and thus deserve
special protections

1

[60]

GA seem very similar to us, but this need not entail 1
special protections since it may be the result of
training or mimicking

[40]

Cognitive and consciousness-related capacities

32

GA can have complex conscious experiences, so
they deserve special protections

19

[3, 13–15, 18, 23, 25–27, 33, 35, 39, 41, 42, 47, 48, 53,
64, 69]

GA have certain sophisticated cognitive capacities
so they deserve special protections

13

[3, 16, 25–27, 33, 35, 37, 41, 46, 47, 63, 69]

Double standards

8

Treating GA with less consideration than humans,
without good reason, is speciesist

7

[18, 29, 32, 33, 42, 49, 63]

Treating GA with less consideration than humans
is inhumane

1

[47]

Vulnerability and dependency

4

Captive GA can be considered vulnerable subjects,
and thus deserve special protections

3

Captive GA are in a special relation of dependency 1
on humans, and thus deserve special protections

[18, 42, 49]
[49]

89

Science
Pro

Scientific and medical value

56

Current GA research has low medical value

12

[2, 13–15, 35, 41, 43, 46–48, 61, 64]

GA research lacks significant scientific value
(unspecified)

6

[13, 17, 27, 41, 43, 48]

The medical value of past GA research need not
predict the medical value of future GA research

2

[44, 62]

Past GA research has been falsely credited as having high medical value

2

[15, 43]

Even if the need of GA to combat an emerging
diseases were justified, their use would not be
possible for logistical and economic reasons

1

[64]

The supposed need of GA research to combat
emerging diseases is unjustified

1

[61]
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Table 3 (continued)
Domain

Position Subdomain and reasons

Con

Pro

Con

N

References

GA have not been key to combating emerging
diseases

1

[26]

Current GA research has high medical value

9

[31, 34, 38, 50, 51, 56, 58, 59, 67]

Past GA research has had high medical value

6

[31, 38, 51, 59, 66, 67]

GA may be needed to combat future emerging
diseases (e.g. Ebola)

4

[12, 50, 66, 67]

Past GA research has had high scientific value

3

[12, 66, 67]

Abandoning GA as research models may slow
down medical discovery

2

[51, 66]

Current GA research has high scientific value

1

[67]

GA research is essential for reducing risks to human 1
research subjects

[67]

The medical value of past GA research is a good
predictor of the medical value of future GA
research

1

[67]

The medical value of GA research may be higher
than it seems, since some GA research supplied
to regulatory agencies is never published

1

[67]

GA research-based medical progress will become
increasingly apparent with time

1

[51]

GA research may become (even more) medically
valuable as a result of new technologies

1

[67]

Restricting GA research could cost human lives

1

[66]

Existence of alternative methods

27

GA research is unnecessary (unspecified)

7

[12, 14, 24, 28, 37, 41, 60]

Alternative, ethical methods (e.g., other animals or
non-animal models) exist

6

[2, 15, 28, 41, 44, 62]

Restricting GA research might drive scientists to
develop alternative research methods

1

[26]

No alternative, ethical methods exist

8

[22, 31, 38, 51, 56, 59, 66, 67]

GA research is necessary (unspecified)

3

[50, 58, 65]

Major medical advances would not have been pos- 2
sible with alternative methods

[12, 67,]

Reliability of methods

6

The methodology of current GA research is questionable (unspecified)

1

[41]

GA used in labs often have multiple diseases and
so are inappropriate research models, scientifically and ethically

1

[24]

The stress that GA face in laboratory life can produce misleading research results

1

[14]

The apparent genetic similarity between GA and
humans need not entail that GA are appropriate
research models

1

[15]

GA have proved to be poor research models, so
investing resources in them may hinder the
advancement of medicine

1

[14]

Con

Given the phylogenetic continuity between GA
and humans, GA are good animal models for
studying human diseases

1

[31]

Pro

GA care and housing requirements are virtually
impossible to meet

5

[2, 17, 26, 47, 61]

The conditions of captive GA are appalling

4

[3, 37, 53, 64]

Pro

32

Welfare

GA care and housing requirements are not actually 2
met

[37, 64]
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Table 3 (continued)
Domain

Position Subdomain and reasons

Con

N

References

The conditions of captive GA can cause GA psychological harms

2

[26, 53]

GA care and housing requirements are particularly
high (unspecified)

1

[64]

GA research sometimes significantly harms GA
(unspecified)

1

[63]

GA research sometimes significantly harms GA
physically

1

[26]

GA research sometimes significantly harms GA
psychologically

1

[26]

Since GA are long-lived, they are used for multiple
protocols, which results in increased suffering

1

[64]

Since GA are long-lived, they can be kept in labora- 1
tories for decades, which is unethical

[26]

Captivity deprives GA of social learning, which is
required for normal development

1

[55]

The benefits of GA research do not outweigh the
harms it causes GA

1

[64]

Although there is great uncertainty regarding
the nature and magnitude of GA suffering, we
should assume that suffering may occur

1

[47]

GA care and housing requirements can actually
be met

3

[40, 56, 59]

GA research can be carried out without significantly harming GA

2

[22, 66]

GA are better off in research facilities (e.g., in terms
of life-expectancy or wellbeing) than in the wild

2

[56, 66]

GA care in research facilities is adequate

1

[66]

GA research is necessary for improving GA welfare

1

[21]

Captive GA that are abandoned by their owners
1
are better off in research facilities than in the wild
since there are no available sanctuaries to keep
them

[56]

24

Public and expert attitudes
Pro

Many other (developed) countries have already
restricted GA research

12

[13, 15, 24, 26, 27, 30, 39, 46, 47, 53, 61, 64]

There is opposition for GA use in research

8

[14, 15, 26, 28, 33, 39, 46, 64]

Many pharmaceutical companies and private
laboratories have already ended GA use

1

[14]

Expert support for invasive GA research has
declined

1

[61]

GA scientists now share concern about GA
research

1

[26]

GA research sometimes requires euthanizing GA,
but euthanizing GA is widely condemned

1

[57]

20

Conservation and retirement
Pro

Con

Supplying GA for research has led to a decline of
wild populations and the threat of extinction

2

[2, 60]

GA are endangered species (unspecified)

2

[26, 64]

Optimal GA retirement should be to return them
to the wild, but this is not feasible

1

[35]

Appeals to conservation do not justify breeding
GA in captivity for research

1

[47]

Conservation efforts could benefit from GA
research

4

[20, 21, 35, 66]
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Table 3 (continued)
Domain

Position Subdomain and reasons
GA could be cared for after research by moving
them to near-wild conditions

N

References

3

[56, 58, 59]

GA research could improve the welfare and protec- 2
tion of GA as a species

[20, 21]

Enough captive GA are already available for
research

2

[56, 65]

Breeding captive GA for research could ensure the
survival of the species

1

[66]

GA could be cared for after research by moving
them to other research facilities

1

[40]

GA could be cared for after research by moving
them to indoor/outdoor facilities

1

[31]

15

Respect and rights
Pro

GA are capable of assenting/dissenting (like
children)

5

[19, 32, 33, 42, 45]

GA can be considered subjects with diminished or
no capacity for informed consent

3

[3, 48, 68]

GA possess enough cognitive capacities to be
considered persons

3

[3, 25, 49]

GA possess enough cognitive capacities to be
considered near-persons or person-like

2

[29, 30]

Given that GA have the same capacities we cite for
humans having the moral right to life, freedom,
and welfare, GA should also be conceived as
having these rights

1

[25]

Given that GA have the capacities that may form
1
the foundation of personhood, they have a moral
right against our intentional infliction of harm

[49]

13

Financial costs
Pro

Con

Required GA care and housing costs are too high
to be cost-effective

3

[2, 47, 61]

Required GA care and housing costs are particularly high

2

[2, 35]

The financial costs of GA research are particularly
high

2

[14, 46]

The benefits of GA research do not outweigh the
financial costs

1

[13]

Given that GA are long-lived, the costs of GA care
and housing after research is particularly high

1

[60]

Funding for GA research continues to decrease,
while the costs of GA research continues to
increase

1

[26]

Many experiments could be carried out with just a
small population of GA

1

[67]

Given that GA are long-lived, the costs of GA care
and housing after research is high but manageable

1

[31]

Restricting GA research could increase medicine
costs

1

[66]

11

Law and legal status
Pro

Some laws and policies already restrict the use of
GA for research

3

[15, 30, 59]

Given their cognitive capacities, GA should be
granted legal personhood

2

[63, 69]

GA should be granted the legal right to liberty

1

[69]
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Table 3 (continued)
Domain

Position Subdomain and reasons

Con

N

References

GA should be granted the legal right not to be
subjected to experiments that are not in their
best interests

1

[63]

GA should be granted the legal right to personal
security

1

[63]

GA should be granted the legal right to life

1

[63]

Laws and policies protecting GA vary in terms of
strictness depending on setting (research, zoos,
or private homes)

1

[21]

Granting legal personhood to GA is a slippery
slope into granting legal personhood to other
animals

1

[54]

7

Longer-term consequences
Pro

Con

Restricting GA research is instrumental for restricting research on other animal species

3

[2, 17, 33]

Restricting GA research is an important first step
away from speciesism against GA

1

[63]

Restricting invasive GA research need not have a
negative impact on non-invasive GA research

1

[16]

Restricting GA research will have a negative impact 2
on non-invasive GA research

Total

[21, 52]

315

Table 4 Cognitive and consciousness-related capacities
used as grounds for granting great apes special
protections
Capacity for

Mentions

Social interaction

14

Complex or sophisticated emotions

13

Rational thought

12

Intense suffering

11

Self-awareness

11

Post-traumatic disorders

9

Sophisticated, human-like capacities (unspecified)

8

Tool use

7

Gestural communication

7

Language acquisition

6

Culture development

5

Imitative learning

5

Symbolic representation

4

Abstract thought

4

Prospective thinking or planning

3

Working or episodic memory

3

Mind reading

3

Complex calculation

2

Social deprivation

2

Sense of humor

2

Sophisticated, human-like capacities in infancy

2

Personality development

1

Social cooperation

1

subdomain, authors sometimes mentioned more specific capacities, which we list in Table 4.
Double standards Reasons in this subdomain make
implicit or explicit appeals to the moral standing of GA
to argue that not giving GA special protections would
amount to unjustifiably giving less moral consideration
to GA than to humans. Most authors argued that this
would be speciesist, while one author argued that it
would be inhumane. All of these reasons were published
in SS&H journals.
Vulnerability and dependency This subdomain comprises reasons that appealed to the vulnerable status of
GA as research subjects to argue for restrictions on GA
research. We categorized reasons about vulnerability
and dependency in the Moral Standing domain because
these notions often arise in virtue of the relationship
between human and nonhuman animals, and such relationships are sometimes taken to be relevant grounds
for moral consideration [70, 71]. These reasons, which
appeared exclusively in SS&H journals, evinced two
main senses of vulnerability: the vulnerability intrinsic
to GA as biological beings (e.g., vulnerability to disease,
illness, or psychological harm), and the situational vulnerability of being used as research subjects (e.g., the
risk of exploitation and increased harm, especially given
captive GA’s status of dependency on researchers).
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Science

Reasons related to science figured prominently in the
debate and were used almost equally to argue for and
against restricting GA research (44 mentions in favor
and 45 against). Reasons in favor were much more common in health sciences journals while reasons against
were mostly mentioned in life sciences journals. We
subcategorized these reasons, in order of frequency, into
three subdomains: (a) Scientific and Medical Value, (b)
Existence of Alternative Methods, and (c) Reliability of
Methods.
Scientific and medical value This subdomain focuses on
the value of invasive GA research for scientific discovery
(what we call “scientific value”) as well as for improving
health and well-being (what we call the “medical value”
of GA research). This is the only subdomain containing
more reasons against than reasons in favor of restrictions.
The main dispute within this subdomain concerns the
medical value of GA research. Those against restrictions appealed to a putative past and the current medical
value of GA research (particularly in relation to HIV and
hepatitis viruses) or cautioned that abandoning GA as
research models may slow down medical discovery. On
the other side, reasons disputed the medical value of previous and current GA research. Similar reasons for and
against restrictions were presented on the scientific value
of GA experiments, concerning areas such as genomics
and behavioral research.
Another point of contention in this subdomain relates
to the potential role of GA research in combating future
emerging diseases such as Ebola. Authors arguing against
restrictions stressed the importance of keeping chimpanzee resources available for that purpose. In favor of
restrictions, authors contended that the supposed need
of GA to combat emerging diseases is not justified, and
that even if it were, the use of GA would not be possible
for logistical and economic reasons.
Existence of alternative methods Several authors
appealed to the (non)existence of alternative methods to
argue for or against GA research. Some disagreed about
the necessity of GA research, a term used to indicate that
there are no acceptable alternatives for highly valuable
biomedical research. Others debated whether alternative research methods were available. Authors favoring
restrictions contended that alternatives (e.g., other animals, non-animal models, or human volunteers) do exist
or that such restrictions may drive scientists to develop
alternative methods (e.g., cell lines that can be infected
with human viruses). Against restrictions, authors primarily argued that sufficient and appropriate alternative
methods are not available (e.g., because chimpanzees are
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the only non-human animal model that can be infected
successfully with certain viruses).
Reliability of methods Reasons in this subdomain focus
on the reliability of methods involving GA research. In
favor of restrictions, authors argued that the methodology
used in current GA research is questionable because, for
example, GA experiments can produce misleading results
due to the multiple diseases that GA used in research tend
to have, or due to the stress GA face in laboratory life.
Divergent views were expressed as to whether the phylogenetic continuity, or apparent genetic similarity, between
GA and humans implies that GA are good animal models
for studying human diseases.
Welfare

Many reasons for and against restricting invasive GA
research focused on GA welfare in research facilities (22 mentions in favor and 10 against). Within
this domain, there was disagreement in three main
areas: (1) care and housing requirements, (2) conditions in research facilities, and (3) harms caused by GA
research. In terms of care and housing, authors favoring restrictions argued that the exacting requirements
of GA care and housing are not, or cannot be, fulfilled
while authors arguing against restrictions put forward
the opposite claim.
With respect to the conditions of GA in research
facilities, authors disagreed as to whether the conditions of captive GA are adequate. Authors favoring
restrictions contended that captivity could cause GA
psychological harms or alter their normal development. In contrast, authors arguing against restrictions
contended that GA are better off (e.g., in terms of lifeexpectancy or wellbeing) in research facilities than they
would be otherwise (e.g., in the wild, or if they were
abandoned by their owners).
Regarding harms to GA resulting from research
activities, authors in favor of restrictions claimed that
GA research sometimes significantly harms GA both
physically and psychologically. Authors also pointed to
the harms GA suffer by virtue of being long-lived: for
instance, that they can be kept in laboratories for decades while being used for multiple research protocols.
Against restrictions, authors argued that GA research
can be carried out without significantly harming GA,
and that GA research is necessary for improving GA’s
own welfare.
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Public and expert attitudes

Reasons appealing to public and expert attitudes were
all used in favor of restricting invasive research with
GA (24 mentions).5 The most frequently cited reason
was that many (especially scientifically advanced) countries have already restricted GA biomedical research.
Authors also indicated as reasons the decrease in public, scientific, or institutional support, or the growing
opposition to the use of GA in research.
Conservation and retirement

Reasons related to conservation and retirement constitute the only domain in which there is a clear predominance of reasons against over those in favor of restricting
GA research (6 mentions in favor and 14 against). Reasons in this domain were more common in scientific
(especially health sciences) journals. Authors arguing
for restrictions—especially those writing until the mid1990s, when chimpanzees bred in captivity were still considered scarce—claimed that supplying GA for research
has led to a decline of wild populations and the threat of
extinction. More recently, with the abundance of chimpanzees bred in captivity, some authors pointed to the
continued endangered status of GA to argue in favor of
restrictions. Conversely, some authors appealed to the
availability of GA in research facilities as an argument
in favor of continuing GA research. Furthermore, some
argued that GA research could benefit GA as a species
on grounds that it could assist conservation efforts (e.g.,
by improving the survival, welfare, and protection of the
species).
Another point of contention regarding research use
of GA relates to their retirement, especially given both
that GA are long-lived and that euthanasia is generally
considered inappropriate in or following GA research.
Against restrictions, authors argued that GA could be
cared for post-experiments in other research facilities or
in alternative indoor/outdoor facilities (e.g., sanctuaries).
In favor of restrictions, one author contended that optimal GA retirement would involve returning them to the
wild, which is not feasible, especially for GA brought up
in captivity (e.g., because they have been deprived from
the opportunity to learn the skills needed for surviving in
the forest).
Respect and rights

Reasons in this domain appeal to the notions of consent,
personhood, and rights and were used solely to argue in

5

Note that although we did not include appeals to others’ claims as reasons
in this review, the reasons advanced in this domain were not simply appeals
to others’ views; they were actively used by authors to support their own arguments. We elaborate on this point in the Discussion.
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favor of restricting GA research (15 mentions). There was
some overlap between the reasons in this domain and the
reasons included in the Moral Standing domain; however,
reasons in this domain were more explicit and suggested
that it is wrong to treat GA in certain ways, irrespective
of the harms that such treatment may cause. Most of the
reasons in this domain appeared in SS&H journals.
Authors appealed to the widely accepted idea that
respect for research subjects requires consent when
appropriate and argued that, like children, GA are capable of assenting or dissenting. Others claimed that GA
should be protected because they can be considered subjects with diminished or no capacity for informed consent. Some authors appealed to the notion of personhood,
arguing that GA possess enough cognitive capacities to
be considered persons (or near-persons, or person-like).
As for moral rights, a few authors argued that since GA
possess the capacities we take as grounding moral rights
(e.g., the right to freedom or welfare), we should regard
GA as having these rights.
Financial costs

Reasons in this domain appeal to the financial costs of
GA research (10 mentions in favor and 3 against). Almost
all these reasons were published in scientific journals.
In favor of restrictions, many argued that the financial
costs required for GA care and housing are too high for
GA research to be cost-effective. Similarly, some authors
drew attention to the financial burden associated with
conducting GA research, including providing them with
long-term care after research (which can last for several decades). Against restrictions, authors argued that
the costs of long-term care are manageable, or that GA
research could be affordable (e.g., by using a small number of animals) and cost-effective in the long-term (e.g.,
by reducing the costs of human healthcare).
Law and legal status

Considerations involving the law and legal status of GA
were mostly used to argue in favor of restrictions on
invasive GA research (9 mentions in favor and 2 against).
The distinction between legal reasons and moral reasons
is important because they are not coextensive: one could
argue, for example, that GA should be granted the legal
right to life without arguing that they also have a moral
right to life. Law and Legal Status is the domain in which
the largest proportion of mentions came from SS&H
journals. Authors appealed to laws and policies already
in place to argue both for and against restrictions. In
favor of restrictions, some authors argued that laws and
policies already restrict the use of GA for research, while
another argued against restrictions by stating that laws
and policies protecting GA vary in terms of strictness
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depending on setting (e.g., research, zoos, or private
homes). Authors also disagreed about whether to grant
GA legal personhood, which would entail conceding
them basic legal rights on a par with those of humans.
Some argued that, given their cognitive capacities, GA
should be granted legal personhood, whereas one author
warned that granting GA legal personhood would place
society on a slippery slope leading to granting legal personhood to other animals.
With respect to granting GA legal rights, a single article made the following four claims: that GA should be
granted legal rights to liberty, to personal security, to
life, and not to be subjected to experiments that are not
in their best interests. No corresponding reasons against
restrictions were offered.
Longer‑term consequences

This domain comprises reasons that appealed to the consequences of GA research in the longer-term (e.g., for
other animals, or for public attitudes about research on
GA or other animals) (5 mentions in favor and 2 against).
In favor of restrictions, some argued that restricting GA
research is instrumental to restrict research on other animals, or that it is an important first step away from speciesism against GA. One point of contention was whether
restricting invasive GA research would have a negative
impact on non-invasive (e.g., behavioral and observational) GA research, due to the decreasing number of GA
kept in colonies.

Discussion
This is the first systematic review addressing the ethics of regulating research with some animal species. We
provided a comprehensive review of academic articles on
the issue of restricting biomedical research with GA. We
identified a total of 110 reason-types, of which 74 were
in favor of and 36 were against restricting GA research.
Previous articles on this topic and in our review offered
a maximum of 15 reason types [cf. 26]. This review thus
offers the most comprehensive overview of the current
debate, as well as a unique analysis of the arguments put
forward in the academic literature. It is also the first systematic review of reasons that identifies articles posing
potential conflicts of interest.
While this review does not attempt to settle the question of whether or not invasive research on GA should
be restricted, it reveals several important insights, both
for advancing this debate and for advancing the debate
on the use of animals more generally in invasive research.
As a result, it can help policymakers make informed decisions, with minimal bias, concerning possible restrictions
to GA research and research with other animal species.
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An academic trend that parallels a regulatory trend
toward restrictions

Our findings suggest a trend in the ethical debate in favor
of restricting GA research that parallels both a more
general social and institutional trend and worldwide
policy changes in the same direction. The use of GA for
research began in the first half of the twentieth century,
but it drastically increased in the 1980s, prompted by the
AIDS epidemic [72]. Seemingly in response to this spike
in GA research, the academic and public debate on the
ethics of this research increased both in the 1980s and in
the 1990s, when the population of chimpanzees in laboratories peaked. This coincides with the U.K.’s 1997 ban
on GA research, which was followed by similar restrictions in many countries in Europe and Oceania [46]. The
academic debate increased again in the years surrounding 2011, when the Institute of Medicine (IOM) issued
a report recommending more demanding standards on
the use of chimpanzees in research. That previous year,
E.U. Directive 2010/63 mandated a ban on the use of GA,
which went into effect in 2013. In 2015, in response to
the IOM’s report, the NIH decided to end the invasive
use of chimpanzees in research (see Fig. 2).
Overall, more than three-quarters of the articles in our
review argued for increasing restrictions on, or banning,
GA research. A similar trend appeared with respect to
the reason-types offered in the literature: the number of
reason-types in favor of restrictions was twice the number of reasons against restrictions. The former were also
mentioned much more frequently than the latter (239
vs 77 mentions). The NIH’s 2015 decision to end invasive chimpanzee research virtually ended such research
worldwide and has been followed by a decline in the academic debate. Only two articles in our review were published after 2016.
Some domains were rather one‑sided

Moral Standing had the highest number of mentions, but
reasons in this domain were rather one-sided. Fifteen
reasons comprising 103 mentions in favor of restricting
GA research were met with just one mention of one reason against. Most reasons within this domain appealed to
the cognitive, consciousness-related, or behavioral capacities of GA to argue in favor of restrictions. Though rarely
made explicit, the rationale behind these reasons was
seemingly the idea that these capacities ground higher
moral standing, and that this standing is crucial in determining whether we should restrict or ban GA research.
(“Higher moral standing” here might mean either higher
than has traditionally been assumed or higher than the
moral standing of most or all other nonhuman animals.)
Although the implicitness of this rationale may stem from
a wider consensus that GA have higher moral standing by
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virtue of their complex or sophisticated capacities, the
rationale itself does raise some questions that were not
addressed in the debate. In particular, is moral standing
the right kind of ground for restricting or banning GA
research? Moreover, do cognitive, consciousness-related,
or behavioral capacities ground moral standing in the first
place? The scholarly debate might therefore advance if
authors engage more explicitly with the reasoning behind
three main ideas: (1) that GA have higher moral standing (in either of the two senses identified above); (2) that
GA’s moral standing warrants them protections that are
not warranted for other animal groups (much as human
beings’ moral standing is assumed to warrant special protections for human subjects); and (3) that GA’s cognitive,
consciousness-related, and/or behavioral capacities are
the basis for their moral standing. Authors might also
wish to explore whether moral standing-related reasons
could extend to other animal species, thereby addressing
the issue of whether GA have higher moral standing than
other research animals.
Another domain characterized by one-sidedness in the
reasons offered is Respect and Rights, in which all reasons
favored restrictions (6 reasons, 15 mentions). Appeals to
cognitive, consciousness-related, or behavioral capacities as grounds for affording GA special protections were
also common in this domain. But, unlike the reasons
presented in Moral Standing, these reasons were more
explicit and elaborate in that they appealed to thicker
ethical concepts as personhood, respect, and rights. The
greater explicitness and elaboration characterizing these
arguments might be explained by the fact that these reasons were published primarily in peer-reviewed articles
in SS&H journals. The domain Respect and Rights offers
fertile ground for advancing the debate on the ethics of
GA research insofar as more developed arguments for
restrictions encourage well-developed counterarguments
and, over time, clearer illumination of the relevant issues.
Moreover, claims about personhood, respect, and rights
might have implications for discussions in the domain
of Law and Legal Status, which contains reasons regarding granting legal personhood to chimpanzees. Overall,
more in-depth discussions regarding these thick ethical
concepts, along with fuller exploration of opposing viewpoints, hold promise for advancing the debate.
Some domains revealed significant engagement
between opposing views

Two domains featured considerable engagement between
positions in favor of and against restricting GA research:
Science and Welfare. These domains, together with
Moral Standing, contained two-thirds of all of the reason
mentions in our review, but unlike the debate in Moral
Standing, the debate in the domains Science and Welfare
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seems to have had a chance to mature. The convergence
of reasons in these domains may reflect an emerging
trend in the animal ethics debate, with authors arguing
that traditional regulatory frameworks (and the “Three
Rs” that serve as their foundation) are insufficient to
ensure the value of animal research for improving health
and wellbeing, especially in relation to research costs,
and is insufficiently protective of the welfare of laboratory animals [73, 74]. After all, many of the reasons in
these domains concerned the scientific or medical value
of GA research and the harms it causes to GA.
Engagement between opposing reasons, albeit with
fewer mentions, was also apparent in three other
domains: Conservation and Retirement, Financial Costs,
and Law and Legal Status. Interestingly, all of these
domains raised concerns particularly relevant to GA.
For example, in Conservation and Retirement, reasons
concerned the fact that GA are scarce, endangered species; in Financial Costs reasons highlighted the high costs
associated with GA housing and long-term care; and in
Law and Legal Status reasons raised concerns about the
legal status of GA—concerns that do not generally arise
for other animals. Insofar as the debate surrounding GA
research has declined due to worldwide restrictions,
we may not expect much more development on these
domains as they apply to GA. But they represent interesting points of discussion that may be extended to debates
involving the use of other animal species, on a case by
case basis.
Diverse, independent views were lacking

Overall, our review revealed low diversity and independence among the views presented in the literature. For
example, most articles (72%) defending a strong position (i.e., favoring a total ban or arguing against restrictions) were associated with institutions that we identified
as taking a position on GA research or animal research
more generally (which we identified as posing potential conflicts of interests; see Additional file 1: Table 2).
Moreover, all U.K.-based authors argued in favor of a
total ban, which is unsurprising given that the U.K. was a
pioneer in phasing out GA research. Similarly, all authors
arguing against restrictions were based in two of the
handful of countries where GA research was conducted
at the time the articles were written: the U.S. (12) and The
Netherlands (1).
This phenomenon, together with the aforementioned
one-sidedness in some domains, is concerning. The
debate on animal research has long been perceived as
locked into polarized and sometimes oversimplified
positions, with neither side listening to the other. The
scholarly debate on restricting GA research might thus
advance if the interaction between academics and the
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public is reimagined as a collaborative effort, in which
the public shapes the debate by organizing and voicing widely-shared concerns and ideals, both in favor of
and against restrictions, and academics step forward to
clarify, evaluate, restructure, and strengthen arguments
that might otherwise be weak or incomplete. In brief,
we might see the role of activists as raising awareness of
important concerns and issues and of academics (either
as observers or participants in advocacy movements) as
adding rigor and balance to the ongoing debate [75]. In
this process and generally, authors should be cognizant
of, and forthcoming about, potential conflicts of interests
when arguing for or against restrictions on GA research.
Scholarly discussion was not the norm

Overall, almost half of the articles in our final list were
opinion pieces or conference proceedings—publications that are less likely to have been peer-reviewed. This
contrasts with previous systematic reviews of reasons
in which the proportion of non-peer-reviewed articles
was much smaller [76]. Even though scholarly bioethics
articles are sometimes not peer-reviewed for editorial
reasons (e.g., in some scientific journals), our findings
suggest that scholarly discussion has not been the norm.
A further contrast with previous reviews, in which
authors were primarily affiliated with academic institutions [77], is that only one-third of corresponding authors
in the present review had such an affiliation, while over
half were affiliated with a private nonacademic institution
or foundation. These facts underscore both a tendency
away from scholarly discussion and the impact that private nonacademic institutions or foundations, including advocacy groups, can have both on shaping scholarly
debates and on generating policy changes.
The tendency away from scholarly discussion may
be further supported by the common use of persuasion
tactics that, while effective for advancing political commitments, may reflect errors in reasoning. For example, authors favoring restrictions frequently appealed to
popular sentiment, decisions by particular countries or
industries, or expert attitudes: there were 25 such mentions, and no mentions against restricting GA research.
Yet, while these appeals may reflect a general social and
institutional trend towards stronger protections for GA—
which may be a legitimate concern for those affected (e.g.,
taxpayers)—they may be interpreted as committing what
in logic is called the fallacy of appeal to authority. Many
authors seem also to have engaged in what can be considered a one-sidedness fallacy—that is, presenting evidence
for a certain viewpoint with little or no effort to engage
with opposing viewpoints. This is evidenced by the fact
that only 2 (3%) of the articles in our entire review cited
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other articles in our review to engage critically with an
opposing viewpoint.
While it is not the place of a systematic review of reasons to measure the quality of the reasons presented in
the literature, our findings nonetheless highlight the need
for a fairer and more balanced scholarly discussion.
Future directions

Given the clear academic and policy trends toward
increasing restrictions on, or banning, GA research, it
seems extremely likely to us that the trend will continue
rather than reverse direction. From the standpoint of
those who believe such a trend is justified rather than
misguided, the growing recognition that animals have
substantial moral standing may appear to reflect a form
of moral progress. However, from the standpoint of those
who do not believe this trend is justified, there are many
avenues for arguments that may alter the direction of this
trend. Either way, one natural avenue for future research
is to explore, in light of the reasons offered in this review,
whether animals other than GA deserve greater research
protections than they currently enjoy.
How plausible would it be to extend the reasons put
forward in the context of the GA debate in judging
whether invasive research on other animal species should
be restricted? In some respects, GA represent a singular case for creating restrictions on research use. Some
reasons that seem to apply well in the case of GA are for
example those within the domains Public and Expert
Attitudes, Conservation and Retirement, and Financial
Costs, but may not apply to animal species that are, say,
less popular among the public, more widespread and
abundant, or less expensive to house and care for. Moreover, certain reasons that were successful in advancing
the case for GA restrictions such as appeals to cognitive
capacities, similarity to humans, or welfare requirements
may only work in a limited set of cases, such as other primates, but excluding, say, rodents.
Further avenues for advancing the debate come from
concerns not found in this review, such as appeals to
moral virtues and vices, animal flourishing, and special
relationships, which may be worth exploring in relation
to the ethics of research with GA or other animal species
or groups. One notable example is the National Academies of Sciences, Engineering, and Medicine report on
canines, which concludes that in certain qualified cases,
it is justified to give dogs preferential treatment by virtue
of our close relationship and societal preference towards
them [6]. Finally, it is worth noting that reasons identified
in this review were predominantly deontological—that
is, focused on rights, duties, or obligations regarding our
treatment to GA—rather than consequentialist. With the
important exception of the domain of Science (in which
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the value of research for society was a key consideration), there was scant systematic discussion of the consequences of restricting or not restricting GA research.
Thus, the domain Longer-term Consequences may provide an interesting path for future work, addressing, for
example, whether restricting, or not restricting, the use of
certain animal species for research may affect other animals, humans, or the environment.
Limitations

Some limitations of this review must be acknowledged.
As we excluded articles that were not published in English, it is possible that this review overlooks arguments
in the non-English literature on regulating GA research.
However, English has become the dominant language in
bioethics publications, which suggests that our review is
representative of the concerns raised in the literature.
The restriction to journal articles—common in systematic reviews in bioethics—might also lead to the exclusion
of certain reasons present in other kinds of publications
(e.g., textbooks). However, it should be noted that at final
stages of data analysis (i.e., based on ten articles added
after perusal of reference lists) our results reached considerable saturation and no new (sub)domains had to be
created.
Another potential limitation involves the different
types of articles included in this review. Insofar as we
included opinion pieces (e.g., commentaries and letters), it is possible that the quality of the reasons offered
is lower than those published in a peer-reviewed journal.
However, we tried to be as systematic and comprehensive
as possible in a field in which explicit ethical arguments
were often put forward in different types of articles, especially in scientific journals. Moreover, given their impact
on policy, excluding expert opinion pieces would have
skewed our review.
A final limitation concerns our categorization: although
we grouped reasons based on their content, and with an
eye towards being informative to the reader, we recognize that some reasons could have been grouped differently. For example, although no consensus exists on how
the notions of harms and wrongs should be distinguished,
we separated reasons involving the notions of respect,
personhood, and rights—notions often associated with
wronging—from reasons involving the cognitive, consciousness-related, or behavioral capacities of GA, which
are often associated with the potential to suffer considerable harm.

Conclusion
Over the last three decades, the use of GA in invasive
biomedical research has generated widespread concern,
both academically and among the public, as well as
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worldwide policy changes in favor of restrictions. This
review shows that the most debated areas in this topic
discuss the scientific and medical value of GA research
as well as the welfare of GA in research. This is consistent with current trends in the animal ethics literature. Still, the most frequently mentioned reasons made
direct or indirect appeal to the moral standing of GA.
These reasons were used almost exclusively to argue
in favor of restrictions and offer several avenues for
advancing the debate.
Authors rarely cited other articles defending an
opposing viewpoint and many domains revealed onesided concerns. Moreover, our findings suggest that
non-academic institutions or foundations, including advocacy groups, have figured prominently in
this debate. This is suggested both by the high number of nonacademic articles that met the criteria to
be included in our final list, and by the high number
of potential conflicts of interests among publications
included in this review, especially those favoring a
strong position either in favor of or against restrictions.
Our findings also call for more transparency and diversity in the debate on GA research, thereby promoting
opportunities to foster collaborative efforts between
academics and the public—efforts that could move the
debate forward. Insofar as the trend towards increasing restrictions on GA research is likely to continue and
extend to other animal species or groups, this review
offers a clear and detailed map of the debate as well as
promising avenues for advancing it.
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